PJP vs. PBE
Compare and contrast key facts about Invesco Dynamic Pharmaceuticals ETF (PJP) and Invesco Dynamic Biotechnology & Genome ETF (PBE).
PJP and PBE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PJP is a passively managed fund by Invesco that tracks the performance of the Dynamic Pharmaceuticals Intellidex Index. It was launched on Jun 23, 2005. PBE is a passively managed fund by Invesco that tracks the performance of the Dynamic Biotech & Genome Intellidex Index (AMEX). It was launched on Jun 23, 2005. Both PJP and PBE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PJP or PBE.
Key characteristics
| PJP | PBE | |
|---|---|---|
| YTD Return | 15.50% | 4.54% |
| 1Y Return | 28.19% | 29.99% |
| 3Y Return (Ann) | 4.35% | -2.85% |
| 5Y Return (Ann) | 8.92% | 6.21% |
| 10Y Return (Ann) | 4.06% | 3.50% |
| Sharpe Ratio | 2.34 | 1.61 |
| Sortino Ratio | 3.12 | 2.36 |
| Omega Ratio | 1.39 | 1.28 |
| Calmar Ratio | 1.74 | 0.84 |
| Martin Ratio | 14.58 | 7.69 |
| Ulcer Index | 2.04% | 4.04% |
| Daily Std Dev | 12.73% | 19.28% |
| Max Drawdown | -37.06% | -45.69% |
| Current Drawdown | -2.07% | -17.85% |
Correlation
The correlation between PJP and PBE is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
PJP vs. PBE - Performance Comparison
In the year-to-date period, PJP achieves a 15.50% return, which is significantly higher than PBE's 4.54% return. Over the past 10 years, PJP has outperformed PBE with an annualized return of 4.06%, while PBE has yielded a comparatively lower 3.50% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PJP vs. PBE - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is lower than PBE's 0.59% expense ratio.
Risk-Adjusted Performance
PJP vs. PBE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Invesco Dynamic Biotechnology & Genome ETF (PBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PJP vs. PBE - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 0.88%, more than PBE's 0.05% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 0.88% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% | 2.96% | 0.44% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% | 0.55% | 0.00% |
Drawdowns
PJP vs. PBE - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, smaller than the maximum PBE drawdown of -45.69%. Use the drawdown chart below to compare losses from any high point for PJP and PBE. For additional features, visit the drawdowns tool.
Volatility
PJP vs. PBE - Volatility Comparison
The current volatility for Invesco Dynamic Pharmaceuticals ETF (PJP) is 3.30%, while Invesco Dynamic Biotechnology & Genome ETF (PBE) has a volatility of 4.63%. This indicates that PJP experiences smaller price fluctuations and is considered to be less risky than PBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.